|
|
|
| QUALIFICATION OF RAW MATERIALS AND CELL SUBSTRATES FOR BIOMANUFACTURING | The quality of starting materials is critical for successful pharmaceutical manufacturing strategies. For biomanufacturing the challenges are further amplified due to the use of a wide variety of raw materials, cell lines, and naturally-derived materials with an increased risk for the intr... | | |
| MAB INDUSTRY IN CHINA : BIOSIMILARS VS INNOVATIVE BIOLOGICS | Following patent cliffs for Erbitux, Rituxan, Sandosta_n and several big blockbusters, Herceptin, Avastin are now among the next biosimilar targets. This is creating huge potential for biosimilars, prompting innovators to shift their focus to target more emerging markets which remain untap... | | |
|